Baxter International Inc. logo

Baxter International Inc. (BAX)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
22. 61
-0.74
-3.1692%
$
11.44B Market Cap
84.13 P/E Ratio
0.07% Div Yield
6.55M Volume
2.59 Eps
$ 23.35
Previous Close
Add Transaction
Day Range
22.59 23.71
Year Range
15.73 29.35
Want to track BAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BAX closed yesterday lower at $22.61, a decrease of -3.1692% from Thursday's close, completing a monthly increase of 21.7555% or $4.04. Over the past 12 months, BAX stock gained 17.1503%.
BAX pays dividends to its shareholders, with the most recent payment made on Jul 01, 2026. The next estimated payment will be in In 2 months on Oct 01, 2026 for a total of $0.01.
The last earnings report, released on Apr 30, 2026, missed the consensus estimates by -0.3152%. On average, the company has fell short of earnings expectations by -0.4817%, based on the last three reports.
Baxter International Inc. has completed 5 stock splits, with the recent split occurring on Jul 01, 2015.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BAX Chart

People also search for

SAP
SAP SE Sponsored ADR
$ 159.04
-1.6085%
Uber Technologies, Inc.
$ 72.46
-2.134%
CRM
Salesforce Inc
$ 170.77
-1.1061%
Capital One Financial Corporation
$ 15.5
+0.2587%
Capital One Financial Corporation
$ 17.57
+0.4%
Reasons to Retain Baxter International Stock in Your Portfolio for Now

Reasons to Retain Baxter International Stock in Your Portfolio for Now

BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.

Zacks | 1 month ago
Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seekingalpha | 1 month ago
Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seekingalpha | 2 months ago

Baxter International Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
TJD
Thomas John Drogan PR Inc.IPAL SECURITIES Inc.
17,083 $537,829.24 $382,061.29 -$155,767.95 -28.96%
TMB
Timothy M. Bidwell Hazlett, BURT & WATSON Inc.
1,500 $116,310 $33,547.5 -$82,762.5 -71.16%
CE
Curtis Ellergodt Rothschild Investment LLC
12,093 $465,384.85 $270,459.94 -$194,924.91 -41.88%
Dodge & Cox
Dodge & Cox Dodge & Cox Funds
51.46M $1.91B $1.15B -$758.37M -39.72%
Tweedy Browne
Tweedy Browne Tweedy, Browne Company LLC
9,739 $383,165.15 $217,819.55 -$165,345.6 -43.15%

Baxter International Inc. (BAX) FAQ

What is the stock price today?

The current price is $22.61.

On which exchange is it traded?

Baxter International Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is BAX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.07%.

What is its market cap?

As of today, the market cap is 11.44B.

Has Baxter International Inc. ever had a stock split?

Baxter International Inc. had 5 splits and the recent split was on Jul 01, 2015.

Baxter International Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Andrew P. Hider CEO
NYSE Exchange
071813109 CUSIP
BR Country
37,500 Employees
1 Jul 2026 Last Dividend
1 Jul 2015 Last Split
27 Oct 1981 IPO Date

Overview

Baxter International Inc. is a global healthcare company with a history dating back to 1931. With its headquarters in Deerfield, Illinois, Baxter specializes in the development and distribution of a wide range of healthcare products aimed at enhancing the health and well-being of people around the world. The company's operations are segmented into four key areas: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. These segments allow Baxter to serve a diverse range of healthcare needs, from critical care to chronic disease management. Baxter's commitment to innovation and quality is evident in its extensive product portfolio and its global presence, selling products in approximately 100 countries through a combination of direct sales force and distributors, including drug wholesalers and specialty pharmacy providers. The company's collaborative efforts, such as agreements with Celerity Pharmaceutical, LLC, and Miromatrix Medical Inc., underscore its dedication to advancing healthcare solutions.

Products and Services

  • Sterile Intravenous (IV) Solutions

    These are critical for patient hydration, medication delivery, and various forms of therapy in clinical settings.

  • Infusion Systems and Devices

    Baxter offers advanced infusion systems and devices that facilitate the safe and precise delivery of IV medications and therapies.

  • Parenteral Nutrition Therapies

    Designed for patients who cannot eat or absorb nutrients through their digestive system, these therapies provide vital nutrition intravenously.

  • Generic Injectable Pharmaceuticals

    The company supplies a range of generic injectables, including essential drugs for acute care settings.

  • Surgical Hemostat and Sealant Products

    These products are utilized to control bleeding and promote healing in surgical procedures.

  • Advanced Surgical Equipment

    Baxter provides state-of-the-art surgical equipment, including surgical video technologies and precision positioning devices, to enhance surgical efficiency and outcomes.

  • Smart Bed Systems

    These systems are designed to improve patient comfort and monitoring capabilities in healthcare settings.

  • Patient Monitoring and Diagnostic Technologies

    Baxter offers technologies for continuous monitoring and diagnosis of patients, aiding in timely and accurate healthcare delivery.

  • Respiratory Health Devices

    Devices designed to assist with breathing disorders and respiratory health management.

  • Dialysis Therapies and Services

    Providing a comprehensive suite of dialysis therapies and services, including peritoneal dialysis (PD) and hemodialysis (HD), Baxter supports patients with chronic kidney failure.

  • Adhesion Prevention Products

    These products are designed to prevent post-surgical adhesions, enhancing patient recovery and comfort.

  • Drug Compounding

    Baxter offers specialized compounding services, allowing for customized medication formulations to meet unique patient needs.

  • Inhaled Anesthesia

    Offering a range of inhaled anesthesia products, Baxter supports anesthesiologists in providing safe and effective sedation for surgical procedures.

Contact Information

Address: One Baxter Parkway, Deerfield, IL, United States, 60015
Phone: 224 948 2000